MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumorsSi Chen, Weiyi Peng|Journal for ImmunoTherapy of Cancer|2024Cited by 18
Shikonin is a novel antagonist of prostaglandin E2 receptor 4 that targets myeloid-derived suppressor cellsYang Wang, Jiacheng He, Wenjuan Liu et al.|Genes & Diseases|2024Cited by 1